We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Rectal Device Enables Easy Medication Administration

By HospiMedica International staff writers
Posted on 25 Feb 2014
A rectal device offers a discrete and comfortable route for giving drugs and liquids, particularly for patients with serious or terminal illness who often lose the ability to swallow. More...


The Macy Catheter is a Silicone-based disposable device, which once placed by a clinician, rests on a patient's leg or abdomen where it is easily accessible for repeat administration of liquids and medications. The device is comprised of a dual port, dual lumen, ballooned tube that is inserted in the rectum until just past the rectal sphincter, where the retention balloon is inflated (via the balloon inflation port) to hold the device in place.

The medication port is specifically designed to be compatible only with oral and enteral connectors, reducing the probability of connection errors. The medication port also features a valve to prevent leakage, and it is designed to be non-clogging. The Macy Catheter is designed to expel with defecation, since it is smaller and softer than typical stool in the rectum, or it can be easily removed prior to a patient’s bowel movement. The Macy Catheter is a product of Hospi (Newark, CA, USA), and has been approved by the US Food and Drug Administration (FDA).

“Rectal administration is a fast, safe and highly effective route of delivery for many medications, especially those used for management of symptoms at the end of life; however, it is often under-utilized in hospice due to the discomfort and embarrassment associated with suppository administration,” said Brad Macy, RN, inventor of the Macy Catheter and co-founder of Hospi. “The Macy Catheter transforms rectal delivery of medication by providing a comfortable and discreet way to administer ongoing medications and liquids without repeated invasion of privacy and suppository administration.”

Although initially the Macy Catheter is intended to be used primarily to manage symptoms for the approximately 1.65 million patients in US hospices each year, the company sees broad applicability for the device whenever a patient has a compromised oral route, such as due to severe nausea and vomiting. Additional relevant market segments include palliative care, home health, skilled nursing, and acute care.

Related Links:

Hospi



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
12-Channel ECG
CM1200B
New
Enteral Feeding Pump
Instilar 1420
New
Sling
GoComfort
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The engine-free, nonlinear, flexible, micro-robotic platform leverages AI to optimize GBM treatment (Photo courtesy of Symphony Robotics)

First-Ever MRI-Steerable Micro-Robotics to Revolutionize Glioblastoma Treatment

Glioblastoma Multiforme (GBM) is one of the most aggressive and difficult-to-treat brain cancers. Traditional surgical procedures, such as craniotomies, involve significant invasiveness, requiring large... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.